A detailed history of Met Life Investment Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 76,777 shares of DVAX stock, worth $937,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,777
Previous 76,777 -0.0%
Holding current value
$937,447
Previous $862,000 0.81%
% of portfolio
0.0%
Previous 0.01%

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$10.73 - $12.58 $90,335 - $105,911
8,419 Added 12.32%
76,777 $862,000
Q1 2024

May 14, 2024

BUY
$11.7 - $14.98 $799,788 - $1.02 Million
68,358 New
68,358 $848,000
Q3 2023

May 09, 2024

BUY
$12.64 - $14.99 $77,457 - $91,858
6,128 Added 9.85%
68,358 $1.01 Million
Q2 2023

Apr 29, 2024

BUY
$9.85 - $13.17 $673,326 - $900,274
68,358 New
68,358 $883,000
Q2 2023

Aug 10, 2023

BUY
$9.85 - $13.17 $60,360 - $80,705
6,128 Added 9.85%
68,358 $883,000
Q1 2023

May 09, 2024

BUY
$9.44 - $11.88 $587,451 - $739,292
62,230 New
62,230 $610 Million
Q3 2022

May 10, 2024

BUY
$9.93 - $17.44 $13,445 - $23,613
1,354 Added 2.22%
62,230 $649,000
Q3 2022

Mar 22, 2023

BUY
$9.93 - $17.44 $13,445 - $23,613
1,354 Added 2.22%
62,230 $649,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $13,445 - $23,613
1,354 Added 2.22%
62,230 $650,000
Q2 2022

May 10, 2024

BUY
$7.45 - $12.83 $24,830 - $42,762
3,333 Added 5.79%
60,876 $766,000
Q2 2022

Jun 20, 2023

SELL
$7.45 - $12.83 $10,087 - $17,371
-1,354 Reduced 2.18%
60,876 $766,000
Q2 2022

Mar 22, 2023

BUY
$7.45 - $12.83 $24,830 - $42,762
3,333 Added 5.79%
60,876 $766,000
Q2 2022

Aug 11, 2022

BUY
$7.45 - $12.83 $24,830 - $42,762
3,333 Added 5.79%
60,876 $766,000
Q1 2022

May 10, 2024

BUY
$9.75 - $14.44 $561,044 - $830,920
57,543 New
57,543 $623,000
Q1 2022

Jun 20, 2023

SELL
$9.75 - $14.44 $45,698 - $67,680
-4,687 Reduced 7.53%
57,543 $623,000
Q1 2022

Mar 22, 2023

BUY
$9.75 - $14.44 $204,594 - $303,008
20,984 Added 57.4%
57,543 $623,000
Q1 2022

May 12, 2022

BUY
$9.75 - $14.44 $204,594 - $303,008
20,984 Added 57.4%
57,543 $624,000
Q4 2021

Jun 21, 2023

SELL
$13.17 - $20.94 $338,087 - $537,550
-25,671 Reduced 41.25%
36,559 $514,000
Q3 2021

May 17, 2024

SELL
$9.16 - $19.83 $52,092 - $112,773
-5,687 Reduced 13.46%
36,559 $702,000
Q3 2021

Jun 21, 2023

SELL
$9.16 - $19.83 $235,146 - $509,055
-25,671 Reduced 41.25%
36,559 $702,000
Q3 2021

Mar 22, 2023

SELL
$9.16 - $19.83 $52,092 - $112,773
-5,687 Reduced 13.46%
36,559 $702,000
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $52,092 - $112,773
-5,687 Reduced 13.46%
36,559 $702,000
Q2 2021

Jun 21, 2023

SELL
$7.25 - $10.99 $144,884 - $219,624
-19,984 Reduced 32.11%
42,246 $416,000
Q1 2021

May 17, 2024

SELL
$4.57 - $11.18 $119,331 - $291,932
-26,112 Reduced 38.2%
42,246 $415,000
Q1 2021

Jun 26, 2023

SELL
$4.57 - $11.18 $91,326 - $223,421
-19,984 Reduced 32.11%
42,246 $415 Million
Q1 2021

Mar 22, 2023

SELL
$4.57 - $11.18 $22,013 - $53,854
-4,817 Reduced 10.24%
42,246 $415,000
Q1 2021

May 14, 2021

SELL
$4.57 - $11.18 $22,013 - $53,854
-4,817 Reduced 10.24%
42,246 $415,000
Q4 2020

May 24, 2024

BUY
$3.73 - $5.6 $20,929 - $31,421
5,611 Added 13.54%
47,063 $209,000
Q4 2020

Jun 22, 2023

SELL
$3.73 - $5.6 $56,572 - $84,935
-15,167 Reduced 24.37%
47,063 $209,000
Q4 2020

Mar 22, 2023

BUY
$3.73 - $5.6 $20,929 - $31,421
5,611 Added 13.54%
47,063 $209,000
Q4 2020

Feb 16, 2021

BUY
$3.73 - $5.6 $20,929 - $31,421
5,611 Added 13.54%
47,063 $209,000
Q3 2020

Jun 26, 2023

SELL
$4.32 - $11.7 $89,760 - $243,102
-20,778 Reduced 33.39%
41,452 $179,000
Q2 2020

May 24, 2024

SELL
$2.94 - $9.1 $79,103 - $244,844
-26,906 Reduced 39.36%
41,452 $368 Million
Q2 2020

Jun 26, 2023

SELL
$2.94 - $9.1 $61,087 - $189,079
-20,778 Reduced 33.39%
41,452 $367,000
Q1 2020

Jul 12, 2023

SELL
$2.27 - $6.2 $47,166 - $128,823
-20,778 Reduced 33.39%
41,452 $146,000
Q4 2019

Jul 12, 2023

SELL
$3.46 - $6.93 $71,891 - $143,991
-20,778 Reduced 33.39%
41,452 $237,000
Q3 2019

Jul 12, 2023

SELL
$2.69 - $4.85 $55,892 - $100,773
-20,778 Reduced 33.39%
41,452 $148,000
Q3 2019

Mar 22, 2023

BUY
$2.69 - $4.85 $34,329 - $61,895
12,762 Added 44.48%
41,452 $148,000
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $34,329 - $61,895
12,762 Added 44.48%
41,452 $148,000
Q2 2019

Jul 12, 2023

SELL
$3.65 - $7.89 $122,421 - $264,630
-33,540 Reduced 53.9%
28,690 $114,000
Q1 2019

Jul 13, 2023

SELL
$7.08 - $12.09 $237,463 - $405,498
-33,540 Reduced 53.9%
28,690 $209,000
Q4 2018

Jul 13, 2023

SELL
$8.14 - $13.28 $273,015 - $445,411
-33,540 Reduced 53.9%
28,690 $262,000
Q4 2018

Mar 22, 2023

SELL
$8.14 - $13.28 $129,580 - $211,404
-15,919 Reduced 35.69%
28,690 $262,000
Q4 2018

Feb 14, 2019

SELL
$8.14 - $13.28 $129,580 - $211,404
-15,919 Reduced 35.69%
28,690 $263,000
Q3 2018

Jul 13, 2023

SELL
$11.85 - $16.0 $397,449 - $536,640
-33,540 Reduced 53.9%
28,690 $355,000
Q3 2018

Mar 22, 2023

SELL
$11.85 - $16.0 $208,808 - $281,936
-17,621 Reduced 28.32%
44,609 $553,000
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $188,640 - $254,704
15,919 Added 55.49%
44,609 $553,000
Q4 2017

Feb 15, 2018

BUY
$17.3 - $24.08 $496,337 - $690,855
28,690
28,690 $537,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.54B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.